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Abstract: Ebstein anomaly is a rare congenital heart disease characterized by a varying degree of
anatomical and functional abnormalities of tricuspid valve and right ventricle. It often coexists
with other congenital cardiac malformations. Up to 79–89% of patients with Ebstein anomaly have
interatrial communication in the form of patent oval foramen or atrial septal defect and more than
one-third has other types of cardiac malformations. Association between Ebstein anomaly and
right aortic arch is extremely rare and only few cases have been described in the literature so far.
Much rarer than with other cardiac malformations, Ebstein anomaly is associated with non-cardiac
malformations or genetic syndromes. Several cases of association between Ebstein anomaly and
Charge syndrome have been reported, nevertheless, Ebstein anomaly accounts for less than 1% of
cardiac defects seen in patients with Charge syndrome. In this case report, we present a unique case
of a patient with Charge syndrome where both Ebstein anomaly and right aortic arch are present.
The diagnosis of Ebstein anomaly and right aortic arch was established prenatally. In the first years of
life, the patient did not exhibit any remarkable symptoms. However, over time, deterioration of right
ventricle function and increased tricuspid regurgitation were observed, requiring consideration of
surgical treatment at the age of five. In addition, delay in physical, motor, and mental development
was observed and thus, at the age of five, the patient was consulted by a medical geneticist and a gene
panel to test for structural heart defects was ordered. The test showed a mutation in chromodomain
helicase DNA binding protein 7 (CHD7) gene, which, along with clinical features, allowed to establish
a diagnosis of Charge syndrome. To the best of the authors’ knowledge, this is the first case report of
a patient with Charge syndrome, Ebstein anomaly, and right aortic arch that has been described in
the literature.
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1. Introduction
Ebstein anomaly is a rare congenital heart disease, comprising only around 1% of all
congenital heart diseases and has an estimated incidence of around 0.5–0.7 in 10,000 live
births [1–3]. It is primarily characterized by a displacement of abnormal tricuspid valve
towards the apex of the right ventricle. The posterior and septal leaflets of the tricuspid
valve are attached to the wall of the right ventricle, while the anterior leaflet of the valve
retains some attachment to the valve ring. The anterior leaflet usually is redundant, sail-like,
may contain fenestrations, and, in some cases, may cause outflow tract obstruction. The
abnormal displaced tricuspid valve causes downward placement of the functional annulus
and splits the right ventricle into two parts. The upper part known as the atrialized part
due to a continuous communication with the right atrium and the lower part consisting
of a normal ventricular myocardium [4]. Due to the reduced size of the functioning
right ventricle and some degree of tricuspid regurgitation, the contractility of the right
ventricle is impaired, resulting in a decrease of effective output from the right side of the
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heart. The right ventricle function can worsen over time if a volume load causes dilatation
and decreases the contractility even further [5]. Most cases of the Ebstein anomaly are
sporadic and the genetic etiology is largely unknown, although mutations in several genes
have been shown to be associated with this condition [6–9]. Overall, it is believed that
genetic, environmental, and reproductive factors are instrumental in the development of
Ebstein anomaly [1–3,10]. As the anatomical features of Ebstein anomaly can have varying
degrees of severity, the clinical course can also vary widely. In mild cases, patients can
be asymptomatic, while in severe cases, marked cyanosis, significant cardiomegaly, and
signs of heart failure can be present right after birth [11,12]. Ebstein anomaly is frequently
associated with other cardiac malformations and, in rarer instances, with non-cardiac
malformations or genetic syndromes. The most common of cardiac malformations are
interatrial communications—patent oval foramen and atrial septal defect, being present
in up to 79–89% of patients [13,14]. Besides interatrial communications, other cardiac
defects are found in 35 to 39% of patients with Ebstein anomaly [2,13,15,16]. Associated
cardiac anomalies include pulmonary stenosis, pulmonary atresia, ventricular septal defect,
cardiomyopathies, coarctation of aorta, bicuspid aortic valve, mitral valve prolapse, and
other rarer abnormalities [2,13,15–19]. Among associated cardiac anomalies, right aortic
arch is extremely rare and only few such cases have been described in the literature so
far [1,20–22]. Non-cardiac malformations or genetic syndromes are found in about 19–22%
of patients with Ebstein anomaly. Ebstein anomaly has been found among patients with
Trisomy 21, Trisomy 9, Trisomy 13, Fragile X syndrome, Noonan syndrome, and other
syndromes [1,2]. Several cases of Ebstein anomaly in patients with Charge syndrome have
also been reported in the literature, but such association is rather rare and Ebstein anomaly
represents less than 1% of all cardiac defects seen in patients with Charge syndrome [23].
In this case report, we present a rare combination of Ebstein anomaly and right aortic arch
in a patient with Charge syndrome, which, to the best of the authors’ knowledge, is the
first such case reported in the literature so far.
2. Case Report
We present a case of a five-year-old female who was diagnosed with Ebstein anomaly
and right aortic arch prenatally at 20 weeks of gestation by fetal echocardiography. The
pregnancy was conceived via in vitro fertilization by 37 years old nullipara woman. Up to
35 weeks of gestation, the mother of the patient used nadroparin and acetylsalicylic acid as
a treatment for a thrombophilia with protein S deficiency. There was no other remarkable
family history and all previous standard pregnancy follow ups were unremarkable.
As pregnancy was conceived via in vitro fertilization and thus regarded high risk,
the woman was referred to our medical center (Children’s Clinical University Hospital in
Riga, Latvia) for fetal echocardiography at 20 weeks of gestation, resulting in the diagnosis
of Ebstein anomaly and right-sided aortic arch. The tricuspid valve was noted to be
dysplastic and apically displaced with mild regurgitation. The size of the right ventricle
was decreased, and aortic arch was coursing to the right of trachea (Figure 1). Further
follow-up visits were done once a month up to the delivery, with no remarkable changes in
the condition.
The patient was born at 40 weeks of gestation in spontaneous vaginal delivery weigh-
ing 3450 g, having a length of 55 cm and an Apgar score of 9/9. At day 4, patient was
transferred to our medical center for further evaluation. Physical exam revealed acro-
cyanosis and systolic murmur, findings of other organ systems were without any significant
deviations from the norm.





Figure 1. Images of fetal echocardiography at 20 weeks of gestation: (a) Transverse gray-scale sonogram of the fetal thorax 
showing aortic arch (RAA) coursing to the right of trachea (*), ductus arteriosus (DA) and superior vena cava (SVC), (b) 
transverse gray-scale sonogram of the fetal heart showing enlarged right atrium (RA), small right ventricle (RV), and 
apically placed dysplastic tricuspid valve. 
The patient was born at 40 weeks of gestation in spontaneous vaginal delivery weigh-
ing 3450 g, having a length of 55 cm and an Apgar score of 9/9. At day 4, patient was 
transferred to our medical center for further evaluation. Physical exam revealed acrocya-
nosis and systolic murmur, findings of other organ systems were without any significant 
deviations from the norm. 
Chest x-ray, electrocardiogram, Holter monitoring, transthoracic echocardiography, 
abdominal ultrasonography, neurosonography, karyotyping, and genetic testing for 
22q11.2 deletion syndrome were done. Transthoracic echocardiography confirmed the 
prenatal diagnosis of Ebstein anomaly and right-sided aortic arch. The electrocardiogram 
showed a partial right bundle branch block. Other examinations and tests done were un-
remarkable. At day 11, patient was discharged home in an overall compensated state 
without any recommendations for pharmacotherapy. 
During the first six months of life, monthly follow up visits were done. The patient’s 
parents had no complaints and imaging studies did not show a significant progression of 
the condition. Further regular follow up visits with a pediatric cardiologist were done 1–
2 times a year. The cardiac function in the first two years of life remained stable. Persistent 
oval foramen was observed, but it closed spontaneously at the age of three. Starting from 
the third year of life, progression of the condition was observed. At the age of four, due to 
progressive dilation of the right atrium and increasing regurgitation of the tricuspid valve, 
a magnetic resonance imaging was done to better assess the heart’s anatomy and aid in 
the consideration of the surgical treatment options. The magnetic resonance imaging 
showed that aortic arch and descending aorta in the mediastinum were located on the 
right side of the trachea in accordance with the previous diagnosis (see Figure 2). It also 
showed the tricuspid valve placed 23 mm apically from the mitral valve, moderate tricus-
pid regurgitation, and decreased ejection fracture of the right ventricle. 
Figure 1. Images of fetal echocardiography at 20 weeks of gestation: (a) Transverse gray-scale sonogram of the fetal thorax
showing aortic arch (RAA) coursing to the right of trachea (*), ductus arteriosus (DA) and superior vena cava (SVC),
(b) transverse gray-scale sonogram of the fetal heart showing enlarged right atrium (RA), small right ventricle (RV), and
apically placed dysplastic tricuspid valve.
Chest x-ray, electrocardiogram, Holter monitoring, transthoracic echocardiography,
abdominal ultrasonography, neurosonography, karyotyping, and genetic testing for 22q11.2
deletion syndrome were done. Transthoracic echocardiography confirmed the prenatal
diagnosis of Ebstein anomaly and right-sided aortic arch. The electrocardiogram showed a
partial right bundle branch block. Other examinations and tests done were unremarkable.
At day 11, patient was discharged home in an overall compensated state without any
recommendations for pharmacotherapy.
During the first six months of life, monthly follow up visits were done. The patient’s
parents had no complaints and imaging studies did not show a significant progression
of the condition. Further regular follow up visits with a pediatric cardiologist were done
1–2 times a year. The cardiac function in the first two years of life remained stable. Persistent
oval foramen was observed, but it closed spontaneously at the age of three. Starting from
the third year of life, progression of the condition was observed. At the age of four, due
to progressive dilation of the right atrium and increasing regurgitation of the tricuspid
valve, a magnetic resonance imaging was done to better assess the heart’s anatomy and aid
in the consideration of the surgical treatment options. The magnetic resonance imaging
showed that aortic arch and descending aorta in the mediastinum were located on the
right side of the trachea in accordance with the previous diagnosis (see Figure 2). It also
showed the tricuspid valve placed 23 mm apically from the mitral valve, moderate tricuspid
regurgitation, and decreased ejection fracture of the right ventricle.
Although karyotyping and genetic testing for 22q11.2 deletion syndrome (DiGeorge
syndrome) were done right after birth and were normal, overtime, some physical, motor,
and mental development delays were observed and thus additional evaluation by medical
genetic was done. It revealed some external ear anomalies, significant growth retardation
(both weight and height below 3rd percentile), which together with congenital heart defects
warranted more detailed genetic testing. The genetic test results revealed mutation in the
chromodomain helicase DNA binding protein 7 (CHD7) gene, which, together with clinical
features, allowed to establish a diagnosis of Charge syndrome.
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Figure 2. Cardiac magnetic resonance imaging (MRI) showing right aortic arch. 
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This case report deals with an extremely rare cardiac malformation combination, 
where Ebstein anomaly and right aortic arch are present in a patient with CHD7 positive 
Charge syndrome. To the best of the authors’ knowledge, thus far, no reports of a combi-
nation of both Ebstein anomaly and right aortic arch in a patient with Charge syndrome 
have been described in the literature. 
Charge syndrome is a rare genetic disorder characterized by a combination of con-
genital anomalies (coloboma of the eye, heart defects, atresia of the choanae, retardation 
of growth, genital abnormalities, and ear abnormalities) mainly caused by de novo muta-
tions in CHD7 gene [24–27]. In our patient, external ear anomalies, heart and aortic arch 
defects, and retardation of growth were present. The cardiac defect is one of the key char-
acteristics of the syndrome and, as our case also highlights, may be one of the most signif-
icant determinants of the patients’ clinical course. The phenotype of cardiac malfor-
mations is highly variable and both isolated and combined heart defects are seen in pa-
tients with Charge syndrome. The most common cardiac malformations are conotruncal, 
septal, and atrioseptal defects. Aortic arch defects are also common and are found in 14–
41% of patients with Charge syndrome that have heart involvement. One of the aortic arch 
defects found in patients with Charge syndrome is right aortic arch [26–30]. 
Right aortic arch is a rare congenital defect of the aorta, in which an aortic arch 
courses to the right of the trachea instead of the left [31–33]. Based on the pattern of the 
origin of the aortic arch branches, several types of right aortic arch can be distinguished 
Figure 2. Cardiac magnetic resonance imaging (MRI) showing right aortic arch.
3. Discussion
This case report deals with an extremely rare cardiac malformation combination, where
Ebstein anomaly and right aortic arch are present in a patient with CHD7 positive Charge
syndrome. To the best of the authors’ knowledge, thus far, no reports of a combination of
both Ebstein anomaly and right aortic arch in a patient with Charge syndrome have been
described in the literature.
C arge syndrome is a rare genetic disorder characterized by a combination of con-
ge it l anomalies (coloboma of the eye, heart defects, tresia of the choanae, retardation
of growth, genital abnormalities, and ear abnormalities) mainly caused by de novo mu-
tations in CHD7 gene [24–27]. In our patient, external ear anomalies, heart and aortic
arch defe ts, and retard tion of growth were present. The cardiac defect is one of the
key characteristics of the syndrome and, as our case also highlights, may be one of th
most significant determinants of the patients’ clinical course. The phenotype of cardiac
malformations is highly variable and both isolated and combined heart defects are seen in
patients with Charge syndrome. The most common cardiac malformations are conotruncal,
septal, and atrioseptal defects. Aortic arch defects are also common and are found in
14–41% of patients with Charge syndrome that have heart involvement. One of the aortic
arch defects found in patients with Charge syndrome is right aortic arch [26–30].
Right aortic arch is a rare congenital defect of the aorta, in which an aortic arch courses
to the right of the trachea instead of the left [31–33]. Based on the pattern of the origin of
the aortic arch branches, several types of right aortic arch can be distinguished [34,35]. The
type most commonly associated with cardiac malformations is the mirror image branching
type. Research shows that 77–100% of patients with mirror image branching type also
have intracardiac malformations [34,36–38]. Moreover, in our reported case the patient had
the right aortic arch of the mirror image branching type. In the mirror image branching
type, the left innominate artery arises as the first branch of the aorta, followed by the
right common carotid and the right subclavian arteries as the second and third branches,
respectively [35]. The position of ductus arteriosus can also vary. The possible variants
include the absence of it, it being positioned on the right connecting descending aorta with
right pulmonary artery, or it being positioned on the left connecting either descending
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aorta or branch vessel to the left pulmonary artery [38]. In most cases, the right aortic arch
of mirror image branching type does not create a vascular ring and thus does not cause
any symptoms [33]. However, around 22% of patients with the right aortic arch of mirror
image branching type have ductus arteriosus positioned on the left connecting descending
aorta with the left pulmonary artery. Such arrangement creates a true vascular ring and
thus can cause symptoms in some patients due to the compression of the trachea and/or
the esophagus [39,40]. The symptoms may include stridor, recurrent upper respiratory
tract infections, respiratory distress, cough, dysphagia, nausea, and vomiting [31,37,41]. In
our reported case, the vascular ring was not formed, and thus patient did not exhibit any
of the aforementioned symptoms.
Despite the fact that, in most cases, patients with mirror branching type right aortic
arch do not experience any symptoms, the presence of right aortic arch still can have
important clinical implications if surgical treatment is necessary for coexisting cardiac or
other malformations [12]. It may be especially important if the surgical management plan
includes placement of the modified Blalock Taussig shunt, in which a synthetic graft is
placed from the innominate or the subclavian artery to the pulmonary artery [42]. The
modified Blalock Taussig shunt is sometimes used as a part of surgical treatment in severely
symptomatic neonates with Ebstein anomaly [43]. In cases where aortic arch courses on
the right, the construction of the modified Blalock Taussig shunt may be difficult and
thus application of further modifications or even alternative surgical methods may be
needed [20,44].
This case highlights the significance of examining the position of the aortic arch and
pattern of its branches in addition to other echocardiographic parameters in Ebstein’s
anomaly as it may, in some instances, explain unaccounted symptoms as well as have
important implications on the decision of surgical management strategy, especially in
severe cases of Ebstein anomaly. In addition, if both Ebstein anomaly and right aortic
arch are present, a patient should be thoroughly examined to look for other congenital
anomalies and also genetic syndromes such as Charge should be considered, especially if
over time retardation of growth is observed.
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